Reviewing Bioqual (OTCMKTS:BIOQ) & OneMedNet (NASDAQ:ONMD)

OneMedNet (NASDAQ:ONMD) and Bioqual (OTCMKTS:BIOQ) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Volatility and Risk

OneMedNet has a beta of -0.55, meaning that its stock price is 155% less volatile than the S&P 500. Comparatively, Bioqual has a beta of -0.32, meaning that its stock price is 132% less volatile than the S&P 500.

Profitability

This table compares OneMedNet and Bioqual’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OneMedNet	N/A	N/A	-116.74%
Bioqual	-0.76%	-1.22%	-0.77%

Earnings and Valuation

This table compares OneMedNet and Bioqual’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OneMedNet	$1.02 million	14.47	-$23.20 million	($0.19)	-3.26
Bioqual	$62.66 million	N/A	$840,000.00	($0.51)	-147.06

Bioqual has higher revenue and earnings than OneMedNet. Bioqual is trading at a lower price-to-earnings ratio than OneMedNet, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings for OneMedNet and Bioqual, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OneMedNet	0	0	0	0	N/A
Bioqual	0	0	0	0	N/A

Insider & Institutional Ownership

0.9% of OneMedNet shares are held by institutional investors. 45.7% of OneMedNet shares are held by insiders. Comparatively, 39.2% of Bioqual shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

OneMedNet beats Bioqual on 6 of the 10 factors compared between the two stocks.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.

About Bioqual

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.